Back to Search
Start Over
The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthma.
- Source :
-
International Forum of Allergy & Rhinology . Jul2024, Vol. 14 Issue 7, p1261-1265. 5p. - Publication Year :
- 2024
-
Abstract
- Key points: In 2021, Medicare spending on biologics was $926 million in Part B (FFS) and $1.3 billion in Part D (FFS/MA).Between 2017 and 2021, annual Medicare spending on biologics increased by approximately 200%.Between 2023 and 2025, Medicare Part D OOP costs for biologics will decrease by an estimated 50%–60%. [ABSTRACT FROM AUTHOR]
- Subjects :
- *NASAL polyps
*MEDICARE Part D
*BIOTHERAPY
*MEDICARE
*SINUSITIS
Subjects
Details
- Language :
- English
- ISSN :
- 20426976
- Volume :
- 14
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- International Forum of Allergy & Rhinology
- Publication Type :
- Academic Journal
- Accession number :
- 178211433
- Full Text :
- https://doi.org/10.1002/alr.23344